×
About 5,450 results

ALLMedicine™ Cystoscopy Center

Research & Reviews  1,632 results

Primary clear cell adenocarcinoma of female urinary tract: a case report and literature...
https://doi.org/10.1186/s12905-022-01835-6 10.1097/RCT.0b013e31816789f4 10.1016/j.ajpath.2013.11.023 10.2214/AJR.16.16929 10.14740/jocmr3500w 10.1016/S0046-8177(96)90064-7 10.1097/RCT.0b013e31816789f4 10.1159/000443020 10.1007/s11255-019-02289-w 10.1046/j.1442-2042.2003.00629.x 10.1016/j.clgc.2011.10.002 10.5306/wjco.v11.i4.243
BMC Women's Health; Miao J, Hu J et. al.

Jun 25th, 2022 - Primary clear cell adenocarcinoma of the urethra is extremely rare, reported only in single case reports, and its histological origin is not clear. There is no standard treatment for CCAU at present, and surgery is still the main treatment for CCA...

Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management ...
https://doi.org/10.1016/j.urolonc.2022.04.012
Urologic Oncology; Pohar KS, Patel S et. al.

Jun 25th, 2022 - The therapeutic benefit of intravesical instillation of hexaminolevulinate (HAL) at the time of transurethral resection of bladder tumor (TURBT) has been demonstrated in multiple studies. The purpose of this study was to prospectively assess the s...

The Impact of Music on Pain and Anxiety During Flexible Cystoscopies
https://clinicaltrials.gov/ct2/show/NCT05429879

Jun 23rd, 2022 - Previous studies have shown that using music as a non-pharmacological intervention is an effective, safe, and inexpensive way to address pain and anxiety in patients during cystoscopies. However few studies have compared patient outcomes between p...

Urine Culture
http://emedicine.medscape.com/article/2093272-overview

Jun 17th, 2022 - Reference Range Urine specimen - No growth in 24-48 hours Next: Interpretation A positive urine culture is based on the growth of bacteria at a high number of colony forming units (CFUs). Urine culture results should be interpreted in conjunction ...

Urine Culture
https://emedicine.medscape.com/article/2093272-print

Jun 17th, 2022 - Urine specimen - No growth in 24-48 hours A positive urine culture is based on the growth of bacteria at a high number of colony forming units (CFUs). Urine culture results should be interpreted in conjunction with clinical symptoms of urinary tra...

see more →

Guidelines  9 results

ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females.
https://doi.org/10.1016/j.jacr.2020.09.003
Journal of the American College of Radiology : JACR; , Venkatesan AM et. al.

Nov 7th, 2020 - Urinary tract infections (UTIs) in women are common, with an overall lifetime risk over >50%. UTIs are considered recurrent when they follow complete clinical resolution of a previous UTI and are usually defined as at least three episodes of infec...

Microhematuria: AUA/SUFU Guideline.
https://doi.org/10.1097/JU.0000000000001297
The Journal of Urology; Barocas DA, Boorjian SA et. al.

Jul 24th, 2020 - Patients presenting with microhematuria represent a heterogeneous population with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific characteristics modify the risk of underlying malignant etiologies, this gui...

No. 397 - Conservative Care of Urinary Incontinence in Women.
https://doi.org/10.1016/j.jogc.2019.04.009
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Dufour S, Wu M

Apr 19th, 2020 - To outline the evidence for conservative care, including both assessment and management options, for urinary incontinence in women. Relevant primary care providers and medical specialists including but not limited to physicians, nurses, midwives, ...

Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From t...
https://doi.org/10.7326/M15-1496
Annals of Internal Medicine; Nielsen M, Qaseem A et. al.

Jan 27th, 2016 - The presence of blood in the urine, or hematuria, is a common finding in clinical practice and can sometimes be a sign of occult cancer. This article describes the clinical epidemiology of hematuria and the current state of practice and science in...

Committee opinion: onabotulinumtoxinA and the bladder.
https://doi.org/10.1097/SPV.0000000000000112
Female Pelvic Medicine & Reconstructive Surgery;

Sep 3rd, 2014 - In January 2013, the US Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have bee...

see more →

Drugs  74 results see all →

Clinicaltrials.gov  301 results

The Impact of Music on Pain and Anxiety During Flexible Cystoscopies
https://clinicaltrials.gov/ct2/show/NCT05429879

Jun 23rd, 2022 - Previous studies have shown that using music as a non-pharmacological intervention is an effective, safe, and inexpensive way to address pain and anxiety in patients during cystoscopies. However few studies have compared patient outcomes between p...

Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
https://clinicaltrials.gov/ct2/show/NCT05415631

Jun 13th, 2022 - Today the standard for the diagnosis and monitoring of bladder tumors is bladder endoscopy. The performance of this exam is not perfect. With this work, based on artificial intelligence, we wish to combine endoscopy with a complementary diagnostic...

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
https://clinicaltrials.gov/ct2/show/NCT05243550

Jun 10th, 2022 - Eligible patients will receive 6 once-weekly intravesical instillations of UGN-102. All patients will return to the clinic approximately 3 months after the first instillation for determination of response to treatment. Assessment of response will ...

Intravesical BCG: is the Urinary Bladder Ready to Receive it
https://clinicaltrials.gov/ct2/show/NCT05335512

Jun 9th, 2022 - This study will be offered to patients who are coming to Tata Memorial Hospital (TMH) for management of Non Muscular Invasive bladder cancer. 10 patients who undergo Transurethral resection of Bladder tumour will be enrolled. Any patient who under...

Evaluating Ovarian Reserve After Conventional Laparoscopy Versus Robotic Surgery for Bilateral Endometrioma
https://clinicaltrials.gov/ct2/show/NCT05357924

Jun 8th, 2022 - Experimental Plan Study design This trial is a prospective, randomized-controlled study investigating postoperative differences in ovarian reserve differing between robot-assisted laparoscopy compared to conventional laparoscopy in patients with b...

see more →

News  153 results

Calcified Urachal Remnant in a Young Adult: An Unusual Case
https://www.mdedge.com/dermatology/article/255140/mixed-topics/calcified-urachal-remnant-young-adult-unusual-case
Allison J. Good, MD, Duane C. Tucker, MD et. al.

Jun 2nd, 2022 - To the Editor: An otherwise healthy 26-year-old man presented to our outpatient clinic with a 15- to 20-mm, shiny, friable-appearing, red umbilical nodule with clear malodorous discharge (Figure 1). The lesion developed 2 weeks prior and gradually.

Value of Screening Urinalysis Prior to Office Procedures Questioned
https://www.medscape.com/viewarticle/974014

May 14th, 2022 - Pre-procedure urinalysis can be skipped before certain office-based urology procedures, such as prostate biopsy and cystoscopy, according to the results of a randomized trial. Some centers perform the pre-procedure test to avoid urinary tract infe...

Neoadjuvant Atezolizumab/Chemo Shows Encouraging Efficacy in Muscle-Invasive Bladder Cancer
https://www.onclive.com/view/neoadjuvant-atezolizumab-chemo-shows-encouraging-efficacy-in-muscle-invasive-bladder-cancer

Mar 23rd, 2022 - The addition of atezolizumab (Tecentriq) to neoadjuvant gemcitabine and cisplatin (GC) generated a high rate of non–muscle-invasive downstaging following radical cystectomy, which correlated with improved relapse-free survival (RFS) and overall su...

Neoadjuvant Chemotherapy Benefit Retains Stronghold for Patients With MIBC, UTUC
https://www.onclive.com/view/neoadjuvant-chemotherapy-benefit-retains-stronghold-for-patients-with-mibc-utuc

Mar 15th, 2022 - Effective treatment paths leveraging neoadjuvant chemotherapy have been well-established for patients with muscle-invasive bladder cancer (MIBC), with mounting retrospective and prospective data continuing to demonstrate overall survival benefit c...

UGN-102 May Provide Alternative to Repetitive Surgery in Low-Grade Intermediate-Risk NMIBC
https://www.onclive.com/view/ugn-102-may-provide-alternative-to-repetitive-surgery-in-low-grade-intermediate-risk-nmibc

Mar 1st, 2022 - Non-surgical primary chemoablation using mitomycin-containing reverse thermal gel UGN-102 produced significant, durable responses in those with low-grade intermediate-risk non–muscle invasive bladder cancer (NMIBC), according to data from the phas...

see more →

Patient Education  11 results see all →